Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-047436
Filing Date
2012-02-09
Accepted
2012-02-09 06:02:16
Documents
10
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d278851d10q.htm 10-Q 250753
2 CERTIFICATION d278851dex311.htm EX-31.1 9831
3 CERTIFICATION d278851dex312.htm EX-31.2 9671
4 CERTIFICATION d278851dex321.htm EX-32.1 5040
  Complete submission text file 0001193125-12-047436.txt   1206606

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mshl-20111231.xml EX-101.INS 122851
6 XBRL TAXONOMY EXTENSION SCHEMA mshl-20111231.xsd EX-101.SCH 8167
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mshl-20111231_cal.xml EX-101.CAL 22841
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mshl-20111231_def.xml EX-101.DEF 19282
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mshl-20111231_lab.xml EX-101.LAB 86053
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mshl-20111231_pre.xml EX-101.PRE 58020
Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MARSHALL EDWARDS INC (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 12584152
SIC: 2834 Pharmaceutical Preparations